<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04946877</url>
  </required_header>
  <id_info>
    <org_study_id>Comorbidities with ADHD</org_study_id>
    <nct_id>NCT04946877</nct_id>
  </id_info>
  <brief_title>Clinical Study of Comorbidities of Attention Deficit Hyperactivity in Children and Adolescents.</brief_title>
  <official_title>Clinical Study of Comorbidities of Attention Deficit Hyperactivity in Children and Adolescents.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Determine the frequency of psychiatric and neurological comorbidities in children and&#xD;
      adolescence diagnosed with ADHD.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      ADHD is a common neurodevelopmental disorder characterized by hyperactivity, impulsivity, and&#xD;
      inattention .ADHD is more often a complex disorder with a high rate of associated co-morbid&#xD;
      conditions. Co-morbid conditions are prevalent among people with ADHD and increase its burden&#xD;
      and complexity of management.Children with ADHD are at a higher risk than children without&#xD;
      ADHD for developing other psychiatric disorders .Motor skill problems and Neurological soft&#xD;
      signs are found in many neuropsychiatric conditions .NSS have been associated with&#xD;
      inattention and behaviour difficulties for decades. Some researchers argue that these signs&#xD;
      should be included in the diagnosis of ADHD .&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 1, 2021</start_date>
  <completion_date type="Anticipated">October 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Determine psychiatric comorbidities in children and adolescents with ADHD using Mini international neuropsychiatric interview for children and adolescents (M.I.N.I. Kid).</measure>
    <time_frame>baseline</time_frame>
    <description>Mini international neuropsychiatric interview for children and adolescents (M.I.N.I. Kid): is structured clinical diagnostic interview designed to assess the presence of current ICD-10 and DSM-IV psychiatric disorders in children and adolescents age 6-17 years</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>determinate presence of soft neurological sign in children and adolescents with ADHD using Cambridge neurological inventory.</measure>
    <time_frame>baseline</time_frame>
    <description>Neurological assessment using Cambridge neurological inventory: this is a clinical instrument constructed for standardized neurological assessment of psychiatric patients. It is useful for identifying neurological soft sign and other patterns of neurological impairments</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Attention Deficit Hyperactivity Disorder</condition>
  <arm_group>
    <arm_group_label>case group</arm_group_label>
    <description>100 ADHD patients; will be taken from outpatient clinic of child and adolescence psychiatry of Assiut university hospitals.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <description>100 normal children; they will be selected from neurology clinic complaining from minor neurological complaint e.g : headache, will match with the case group for age, sex and educational level.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>IQ assessment using Wechsler intelligence scale for children third edition (WISC-III)</intervention_name>
    <description>IQ assessment using Wechsler intelligence scale for children third edition (WISC-III): is consists of several subtests, each classified into a verbal or performance scale .</description>
    <arm_group_label>case group</arm_group_label>
    <arm_group_label>control group</arm_group_label>
    <other_name>Mini international neuropsychiatric interview for children and adolescents (M.I.N.I. Kid)</other_name>
    <other_name>Child behavior checklist (CBCL), parent form</other_name>
    <other_name>Neurological assessment using Cambridge neurological inventory</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Case group will include 100 ADHD patients; will be taken from outpatient clinic of child&#xD;
        and adolescence psychiatry of Assiut university hospitals.&#xD;
&#xD;
        Control group will include 100 normal children; they will be selected from neurology clinic&#xD;
        complaining from minor neurological complaint e.g : headache, will match with the case&#xD;
        group for age, sex and educational level.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age: 6-17 years.&#xD;
&#xD;
          -  Sex: both sexes will be included in the study.&#xD;
&#xD;
          -  IQ≥70.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age: less than 6 years or more than 17 years.&#xD;
&#xD;
          -  IQ&lt;70.&#xD;
&#xD;
          -  Patients with major neurological deficits, cerebral palsy and uncontrolled epilepsy.&#xD;
&#xD;
          -  Patients with major psychiatric disorders e.g schizophrenia spectrum disorder.&#xD;
&#xD;
          -  Patient who refusing to participate in the study or their caregiver refusing to give&#xD;
             informed consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>salma mohmed fahmi, msc</last_name>
    <phone>01067151755</phone>
    <email>saloma151@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ahmed Abdelbaky Abd elrahman, MD</last_name>
  </overall_contact_backup>
  <reference>
    <citation>Gillberg C, Gillberg IC, Rasmussen P, Kadesjö B, Söderström H, Råstam M, Johnson M, Rothenberger A, Niklasson L. Co-existing disorders in ADHD -- implications for diagnosis and intervention. Eur Child Adolesc Psychiatry. 2004;13 Suppl 1:I80-92. Review.</citation>
    <PMID>15322959</PMID>
  </reference>
  <reference>
    <citation>Faraone SV, Asherson P, Banaschewski T, Biederman J, Buitelaar JK, Ramos-Quiroga JA, Rohde LA, Sonuga-Barke EJ, Tannock R, Franke B. Attention-deficit/hyperactivity disorder. Nat Rev Dis Primers. 2015 Aug 6;1:15020. doi: 10.1038/nrdp.2015.20. Review.</citation>
    <PMID>27189265</PMID>
  </reference>
  <reference>
    <citation>Jensen CM, Steinhausen HC. Comorbid mental disorders in children and adolescents with attention-deficit/hyperactivity disorder in a large nationwide study. Atten Defic Hyperact Disord. 2015 Mar;7(1):27-38. doi: 10.1007/s12402-014-0142-1. Epub 2014 Jun 19.</citation>
    <PMID>24942707</PMID>
  </reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 23, 2021</study_first_submitted>
  <study_first_submitted_qc>June 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 1, 2021</study_first_posted>
  <last_update_submitted>June 23, 2021</last_update_submitted>
  <last_update_submitted_qc>June 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Salma Mohmed</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <keyword>ADHD,comorbidities</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperkinesis</mesh_term>
    <mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

